Articles tagged "Donation"

2015 American Transplant Congress
Age Should Not Be Considered a Contraindication for Living Kidney Donation
D.-A. Moutzouris, R. Charif, J. Galliford, J. McDermott, H. Dulku, H. Orr, D. Taube, M. Loucaidou.
Imperial College Renal and Transplant Centre, Hammersmith Hospital, London, United Kingdom.
The increasing numbers of patients with ESRD on the transplant waiting list has been the main driving force for expanding the donor pool. Acceptance of…
2015 American Transplant Congress
Living Donor Transplant Rates in Children Are Declining
D. Keith, A. Nishio Lucar, G. Vranic.
University of Virginia, Charlottesville, VA.
Living donor (LD) transplant rates have been declining since 2004 in adult candidates. We sought to determine if this trend is also occurring in pediatric…
2015 American Transplant Congress
Kidney Transplantation Using Kidneys from Donation After Circulatory Death Donors: Results from the UK Experience
D. Summers,^1,2,3 R. Johnson,² D. Collett,² C. Watson,^1,3 J. Neuberger,² G. Pettigrew,^1,3 J. Bradley.^1,3
¹Department of Surgery, Cambridge University, Cambridge, United Kingdom; ²Organ Donation and Transplantation, NHS Blood and Transplant, Bristol, United Kingdom; ³Cambridge NIHR Biomedical Reseach Centre, Cambridge, United Kingdom.
Introduction: Kidneys from donation after circulatory-death donors currently make up over 40% of deceased donor kidney transplants in the UK. In addition, 34% of deceased…
2015 American Transplant Congress
Excellent Outcomes With Deceased Donor Kidney Transplants With a Terminal Creatinine >= 3
L. Matsuoka,¹ E. Alicuben,¹ K. Woo,¹ H. Shidban,¹ Y. Qazi,² M. Smogorzewski,² S. Alexopoulos.¹
¹Department of Surgery, USC Keck School of Medicine, Los Angeles, CA; ²Department of Nephrology, USC Keck School of Medicine, Los Angeles, CA.
Purpose: Kidneys from deceased donors with elevated creatinine are frequently discarded due to concerns about poor post-transplant outcomes. In this study we sought to determine…
2015 American Transplant Congress
Eculizumab as a Rescue Therapy for Rhinovirus-Induced Antibody Mediated Rejection After Incompatible Kidney Transplantation
E. Tantisattamo, A. Shetty, B. Ho, L. Gallon, J. Friedewald.
Northwestern University, Chicago, IL.
Background: Despite being an effective strategy for overcoming ABO and HLA incompatibilities, desensitized kidney transplantation still has limitations. Early antibody mediated rejection (ABMR) may be…
2015 American Transplant Congress
Clinical Outcomes of Living Kidney Donors With Medullary Sponge Kidney
W. Cheungpasitporn, C. Thongprayoon, B. Brabec, W. Kittanamongkolchai, S. Erickson.
Nephrology and Hypertension, Mayo Clinic, Rochester, MN.
Background: Patients with medullary sponge kidney (MSK) commonly encounter recurrent nephrolithiasis. The objective of this study was to assess the clinical and safety outcomes of…
2015 American Transplant Congress
Age, Race and Socioeconomic Factors Have a Strong Influence on Candidates Finding a Living Donor Kidney
G. Vranic, A. Nishio Lucar, D. Keith.
Medicine, University of Virginia, Charlottesville, VA.
Living donation is decreasing in the US even as the number of candidates listed for renal transplant continues to rise. We sought to evaluate the…
2015 American Transplant Congress
Legal Issues in Domino Liver Transplantation in Germany
H. Schmidt,¹ A. Barreiros,² H. Schlitt,² T. Gutmann.³
¹Klinik für Transplantationsmedizin, Universitätsklinikum Münster, Münster, Germany; ²Universitätsklinikum Regensburg, Regensburg, Germany; ³Rechtswissenschaftliche Fakultät, Westfälische Wilhelms-Universität Münster, Münster, Germany.
TTR-amyloidosis (FAP) is caused by TTR variants expressed and secreted by the liver. Therefore, liver transplantation was introduced as therapeutic option to prevent or limit…
2015 American Transplant Congress
Development of a Targeted Genetic Renal Disease Panel With NexGen Sequencing for Unbiased Testing of Living Kidney Donors for Genetic Kidney Disease
C. Thomas,¹ Z. Stewart,³ A. Mansilla,² S. Mason,² A. Kwitek,² C. Campbell,² R. Smith,^1,2 R. Smith.^1,2
¹Internal Medicine, University of Iowa, Iowa City, IA; ²Institute of Human Genetics, University of Iowa, Iowa City, IA; ³Surgery, University of Iowa, Iowa City, IA.
Recent studies indicate that living donors biologically related to their transplant recipient may be at higher risk of ESRD compared to unrelated donors, possibly secondary…
2015 American Transplant Congress
Liver Allograft Utilization Within the United States: 2003-2013
J. Renz,¹ G. Diaz,¹ L. Ratner,² H. Yersiz,³ M. Millis,¹ J. Matthews.¹
¹Department of Surgery, University of Chicago, Chicago, IL; ²Department of Anesthesia/Critical Care, University of Chicago, Chicago, IL; ³Department of Surgery, Columbia University, New York, NY; ⁴Department of Surgery, University of California Los Angeles, Los Angeles, CA.
Objectives: 1) Evaluate liver allograft availability, utilization, and failure probability utilizing the liver donor risk index(LDRI) 2) Correlate allograft utilization with waitlist mortality and incidence…